An agonist of RORA stimulated lipid metabolism by inducing microRNA-122 expression in a mouse model of nonalcoholic steatohepatitis, which subsequently reduced hepatic lipotoxicity and fibrosis [22]. This evidence concerns the gene RORA and metabolic dysfunction-associated steatohepatitis.